These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15644946)

  • 1. Cytochrome p450 enzymes and cardiovascular disease.
    Hunter AL; Cruz RP; Cheyne BM; McManus BM; Granville DJ
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1053-60. PubMed ID: 15644946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 enzymes and the heart.
    Chaudhary KR; Batchu SN; Seubert JM
    IUBMB Life; 2009 Oct; 61(10):954-60. PubMed ID: 19787709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 enzymes: central players in cardiovascular health and disease.
    Elbekai RH; El-Kadi AO
    Pharmacol Ther; 2006 Nov; 112(2):564-87. PubMed ID: 16824612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome p450 2C (CYP2C) in ischemic heart injury and vascular dysfunction.
    Chehal MK; Granville DJ
    Can J Physiol Pharmacol; 2006 Jan; 84(1):15-20. PubMed ID: 16845886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450s and cholesterol homeostasis.
    Pikuleva IA
    Pharmacol Ther; 2006 Dec; 112(3):761-73. PubMed ID: 16872679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450: another player in the myocardial infarction game?
    Sunder-Plassmann R
    Adv Clin Chem; 2007; 43():229-80. PubMed ID: 17249386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications.
    Zhang YY; Yang L
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):621-9. PubMed ID: 19473111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
    Dutheil F; Beaune P; Loriot MA
    Biochimie; 2008 Mar; 90(3):426-36. PubMed ID: 17997991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
    Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
    Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 polymorphism--molecular, metabolic and pharmacogenetic aspects. I. Mechanisms of activity of cytochrome P450 monooxygenases.
    Pachecka J; Tomaszewski P; Kubiak-Tomaszewska G
    Acta Pol Pharm; 2008; 65(3):303-6. PubMed ID: 18646549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
    Guéguen Y; Mouzat K; Ferrari L; Tissandie E; Lobaccaro JM; Batt AM; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Souidi M
    Ann Biol Clin (Paris); 2006; 64(6):535-48. PubMed ID: 17162257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cardiac cytochrome P450 in patients with heart failure.
    Aspromonte N; Monitillo F; Puzzovivo A; Valle R; Caldarola P; Iacoviello M
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):327-39. PubMed ID: 24387291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
    Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
    Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
    Murray M
    J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A; Komorowski J; Wikberg JE
    J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.
    Elbarbry FA; Marfleet T; Shoker AS
    Transplantation; 2008 May; 85(9):1222-9. PubMed ID: 18475175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine invertebrate cytochrome P450: emerging insights from vertebrate and insects analogies.
    Rewitz KF; Styrishave B; Løbner-Olsen A; Andersen O
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Aug; 143(4):363-81. PubMed ID: 16769251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.